5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01
Published October 9, 2013 · Recall initiated: August 29, 2013
Summary
FDA records drug Class II recall D-66201-001, published October 9, 2013 and initiated August 29, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 86,400 ampuls; Lot: Lot 23-227-DK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; report of visible particulates in the glass ampule
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot 23-227-DK
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, RxMay 31, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
- FDASymbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List numberNovember 16, 2016
- FDAHistamine, 10 ng/mL Injectable, MDV, Rx only, Triangle Compounding Pharmacy, 3700 Regency Parkway, Suite 140,October 9, 2013
- FDAEstradiol 1.25 mg, Progesterone 25 mg/mL injectable, 20 mL sterile vials, The Apothecary Shoppe, 6136 E. 51stOctober 9, 2013
Questions about this recall
Was 5% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2 mL Single Dose Ampuls, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01 recalled?
Yes. FDA published recall D-66201-001 on October 9, 2013. Reported hazard: Presence of Particulate Matter; report of visible particulates in the glass ampule
What should I do if I have this product?
Voluntary: Firm initiated · Letter